The benefit of aspirin
in reducing cardiovascular (CV) events or mortality in those patients with
known CV disease (secondary prevention) is well established. However, the benefit of aspirin in those
without CV disease (primary prevention) is less clear. Various organizations have differing opinions
and recommendations regarding who, if anyone, should receive aspirin in this
capacity, and their recommendations are summarized further below. To go straight to the current recommendations, skip down to 'Current Recommendations'.
HughesMedicine - Pharmacotherapy Pearls from the Internal Medicine Clinical Pharmacist
Recommended for you
-
Let’s start with a patient case. A patient is being treated with methylprednisolone 20 mg IV q6 hours for some inflammatory process and...
-
There are many different insulin preparations and supplies available in order to create individualized regimens for patients. Here are s...
-
A 55 year old business executive is being discharged from the hospital after a brief admission for cellulitis. His only PMH is HTN and o...
-
Daptomycin (Cubicin) is the first antibiotic in a class known as lipopeptides and has a unique mechanism of action. Daptomycin is a large...
-
A 65 year old male is being treated for an infection on his forearm that developed purulent drainage within the last few days. He denies ...
-
(Click to enlarge) Vancomycin was the first antibiotic developed of the glycopeptide class. It is termed "glyco-" becaus...
-
Midodrine is a peripherally-acting selective alpha1 receptor agonist . Let's take that sentence apart to see what we should expect ...
-
A 74 year old female patient presents to clinic describing dysuria and urinary frequency that started within the last few days. She has ...
-
A 48 year old male is admitted to the hospital after experiencing a fever and malaise for several days. He states that he has some shortn...
-
Let’s start with a patient case. A patient is admitted to the hospital with a CHF exacerbation. They are taking warfarin for atrial fi...